RT Journal
T1 Clarification of conflict of interest disclosures in: Preventing depression: a global priority
JF JAMA
JO JAMA
YR 2012
FD June 6
VO 307
IS 21
SP 2259
OP 2259
DO 10.1001/jama.2012.5453
UL http://dx.doi.org/10.1001/jama.2012.5453
AB 
Clarification of Conflict of Interest Disclosures:  In a Viewpoint entitled, “Preventing Depression: A Global Priority,” published in the March 14, 2012, issue of JAMA (2012;307[10]:1033-1034), the conflict of interest disclosure for Dr Reynolds should have read as follows: “Dr Reynolds reported receiving pharmaceuticals for research studies from Bristol-Myers Squibb, Forest, Pfizer, and Lilly; receiving grants from the National Institute of Mental Health, National Institute on Aging, National Center on Minority Health and Health Disparities, National Heart, Lung, and Blood Institute, the Commonwealth of Pennsylvania, the John A Hartford Foundation, and the American Foundation for Suicide Prevention; and serving on the American Association for Geriatric Psychiatry editorial review board.” A letter regarding the correction appears in this issue. The article has been corrected online.